The prognostic significance of CD45+, CD4+, CD8+, and PD-1+ lymphocyte counts and PD-1+/CD8+ lymphocyte ratios in PBMCs was similar to that observed for TILs from the GBM histology sections. The gene discussed is CD8A; the disease is glioblastoma.